<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="893">
  <stage>Registered</stage>
  <submitdate>26/09/2005</submitdate>
  <approvaldate>26/09/2005</approvaldate>
  <nctid>NCT00226837</nctid>
  <trial_identification>
    <studytitle>Quantifying Nitrous Oxide Effect on Depth of Anaesthesia Using Theoretically Based Time Series Modelling</studytitle>
    <scientifictitle>Quantifying Nitrous Oxide Effect on Depth of Anaesthesia Using Theoretically Based Time Series Modelling</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>2004.109</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Depth of Anaesthesia</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Nitrous oxide

Placebo Comparator: 1 - 0% nitrous oxide

Active Comparator: 2 - 33% nitrous oxide

Active Comparator: 3 - 66% nitrous oxide


Treatment: drugs: Nitrous oxide
nitrous oxide by inhalation during induction

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>EEG index value during three concentrations of nitrous oxide</outcome>
      <timepoint>During induction of anaesthesia</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Aged 18 years or older

          -  Presenting for surgery under general anaesthesia</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Poor English language comprehension

          -  Risk of reflux

          -  Epilepsy or other EEG abnormality</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2004</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>60</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/08/2005</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Swinburne University - Hawthorn</hospital>
    <hospital>Royal Melbourne Hospital - Parkville</hospital>
    <postcode>3123 - Hawthorn</postcode>
    <postcode>3050 - Parkville</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Melbourne Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Australian and New Zealand College of Anaesthetists</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Our hypothesis is that a new method of depth of anaesthesia monitoring, using theoretically
      based time series modelling will result in improved ability to determine nitrous oxide
      anaesthetic effect</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00226837</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Kate Leslie, MD</name>
      <address>Melbourne Health</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>